Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
The Journal of Urology
|
November 1, 1979
Simple transvesical repair of vesicovaginal fistula
R R Landes
The Journal of Infectious Diseases
|
August 1, 1976
Single daily doses of tobramycin in therapy of urinary tract infections
R R Landes
Urology
|
May 1, 1981
Cinoxacin for treatment and prevention of recurrent urinary tract infection
R R Landes
British Journal of Haematology
|
October 1, 1976
Activation of platelets by platelet activating factor (PAF) derived from IgE-sensitized basophils. IV. PAF does not activate platelet factor 3 (PF3)
P M Henson, R R Landes
Urology
|
October 1, 1977
Cinoxacin: new antimicrobial agent for urinary tract infections
R R Landes, J W Hall
American Family Physician
|
January 1, 1981
Scrotal palpation
D H Zornow, R R Landes
The American Journal of Pathology
|
September 1, 1981
Biochemical mechanisms of lipid-A-mediated enhancement of platelet secretory responses to aggregated immunoglobulins
R R Landes, D C Morrison
Urology
|
January 1, 1977
Vesical exstrophy with epispadias. Twenty-year follow-up
R R Landes, I Melnick, R Klein
Urology
|
October 1, 1976
Effect of preoperative antibiotic therapy on bacterial prostatitis after transurethral prostatectomy
R R Landes, K Medenbach, R E Lee
Investigative Urology
|
May 1, 1978
The frequency of urolithiasis in hospital discharge diagnoses in the United States
R Sierakowski, B Finlayson, R R Landes, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
The Journal of Urology
|
November 1, 1979
Simple transvesical repair of vesicovaginal fistula
R R Landes
The Journal of Infectious Diseases
|
August 1, 1976
Single daily doses of tobramycin in therapy of urinary tract infections
R R Landes
Urology
|
May 1, 1981
Cinoxacin for treatment and prevention of recurrent urinary tract infection
R R Landes
British Journal of Haematology
|
October 1, 1976
Activation of platelets by platelet activating factor (PAF) derived from IgE-sensitized basophils. IV. PAF does not activate platelet factor 3 (PF3)
P M Henson, R R Landes
Urology
|
October 1, 1977
Cinoxacin: new antimicrobial agent for urinary tract infections
R R Landes, J W Hall
American Family Physician
|
January 1, 1981
Scrotal palpation
D H Zornow, R R Landes
The American Journal of Pathology
|
September 1, 1981
Biochemical mechanisms of lipid-A-mediated enhancement of platelet secretory responses to aggregated immunoglobulins
R R Landes, D C Morrison
Urology
|
January 1, 1977
Vesical exstrophy with epispadias. Twenty-year follow-up
R R Landes, I Melnick, R Klein
Urology
|
October 1, 1976
Effect of preoperative antibiotic therapy on bacterial prostatitis after transurethral prostatectomy
R R Landes, K Medenbach, R E Lee
Investigative Urology
|
May 1, 1978
The frequency of urolithiasis in hospital discharge diagnoses in the United States
R Sierakowski, B Finlayson, R R Landes, et al.
Page
of 2